Sat.Nov 13, 2021 - Fri.Nov 19, 2021

article thumbnail

FDA clears GE Healthcare AI algorithm for patient intubation

pharmaphorum

An artificial intelligence algorithm developed by GE Healthcare that helps with the placement of endotracheal tubes (ETTs) has been approved by the FDA. The new tool – part of GE’s Critical Care Suite 2.0 – helps bedside staff and radiologists assess patients before intubation – for example prior to ventilation in patients with critical COVID-19 – and make sure their ETTs are positioned correctly.

FDA 145
article thumbnail

Medicare startup EasyHealth gets $135M in series A to fill information gaps

Fierce Healthcare

Medicare startup EasyHealth gets $135M in series A to fill information gaps. rtorrence. Fri, 11/19/2021 - 10:10.

143
143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Gene-edited cell replacement therapy for diabetes set to enter the clinic

Outsourcing Pharma

CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D).

article thumbnail

WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD

Pharma Tutor

WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD. Recently, during inauguration of Global Innovation Summit of the pharmaceuticals sector Indian Prime Minister Shri Narendra Modi addressed, India as the Pharmacy of the world. He said that our definition of wellness is not limited by physical boundaries. We have exported life-saving medicines and medical equipment to over 150 countries during the initial phase of the pandemic.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Boost for Amazon’s telehealth business, as Hilton signs up

pharmaphorum

Amazon’s push into the provision of remote healthcare services has been rewarded with a top-tier corporate client – the Hilton hotel chain. The deal – first reported by Reuters – involves the Amazon Care platform, which includes remote, online consultations with clinicians, as well as home visits in some areas. It provides primary and preventive care, ongoing support for chronic conditions, and referrals to secondary and tertiary care.

Hospitals 133
article thumbnail

Biden admin finalizes rule that requires insurers to submit data on drug costs, rebates

Fierce Healthcare

Biden admin finalizes rule that requires insurers to submit data on drug costs, rebates. pminemyer. Wed, 11/17/2021 - 16:42.

Insurance 136

More Trending

article thumbnail

Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022

Pharma Mirror

Amsterdam, CPhI Worldwide (9-11 November, 2021), which held its first in-person event since 2019, hosted the global pharma community at the Fiera Milano, Milan, welcoming exhibitors and attendees from 146 countries. This year’s smart event was a combination of a three-day live exhibition, and a month-long online event featuring both the latest market insights through live and on demand content sessions and of course networking opportunities.

52
article thumbnail

AZ, Moderna say mRNA drug is promising in heart failure

pharmaphorum

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart failure. At the American Heart Association (AHA) congress, the two partners presented results from the phase 2a EPICCURE trial that showed that injecting their AZD8601 candidate directly into the heart muscle of patients undergoing coronary artery bypass graft (CABG) surgery seemed to improve heart functio

Vaccines 130
article thumbnail

Here are the policies and reforms that could reshape healthcare in the $2T bill just passed by the House

Fierce Healthcare

Here are the policies and reforms that could reshape healthcare in the $2T bill just passed by the House. rking. Fri, 11/19/2021 - 10:09.

130
130
article thumbnail

AstraZeneca: lupus drug candidate shows promise in Phase III trial

Outsourcing Pharma

According to the pharma firm, Saphnelo (anifrolumab) combined with standard therapy resulted in reduction of systemic lupus erythematosus disease activity.

93
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China

Pharma Mirror

Shanghai, China’s pharma industry has seen a record improvement in its overall score, growth potential and biologics according to new data. The China specific findings of the CPhI Annual Report rankings[1] are released ahead of CPhI & P-MEC China – which will take place in hybrid form, with Virtual Expo Connect running digitally from November 18th until December 18th, and the in-person event held at the Shanghai New International Expo Center (SNIEC) December 16-18th, 2021.

52
article thumbnail

Respira Labs’ wearable device listens for lung diseases

pharmaphorum

US company Respira Labs has developed a device worn on the chest that uses tiny speakers and microphones to project sound into the lungs and listen for signals that could indicate serious lung diseases. The Sylvee wearable uses an artificial intelligence (AI) algorithm to interpret sounds that may indicate trapped air in the lungs, which can be a sign of ill health, using acoustic resonance – similar to the way an ultrasound machine creates visual images.

Hospitals 122
article thumbnail

MedArrive nabs $25M to ramp up at-home health services, expand into new states

Fierce Healthcare

MedArrive nabs $25M to ramp up at-home health services, expand into new states. hlandi. Fri, 11/19/2021 - 16:56.

141
141
article thumbnail

More sites and sponsors betting on decentralized format: Science 37

Outsourcing Pharma

According to data released by the company, the majority of study professionals plan to run agile or hybrid trials over the course of the next 12 months.

91
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

What to Consider before Joining the Great Resignation

McCreadie Group

November 2021 | Michael Schlesselman, Pharm.D., FASHP In his blog, Michael Schlesselman advises employees to carefully consider their goals, opportunities, and finances before joining the Great Resignation and leaving their current positions behind. Dr. Schlesselman is the Director of Research Products at McCreadie Group and leads a remote team of pharmacists, technicians, and analysts in.

52
article thumbnail

Parliamentary probe finds racism evidence in NHS sickle cell care

pharmaphorum

Patients with sickle cell disease are facing racism in the NHS that is putting their lives a risk, claims a new report. . The All-Party Parliamentary Group (APPG) document – entitled No One’s Listening and partnered with the Sickle Cell Society – found “serious care failings” in acute services and evidence of attitudes underpinned by racism in the care of people with SCD, a red blood cell disorder that mainly affects black people.

article thumbnail

Experts weigh in on ways to combat growing antibiotic resistance amid COVID-19

Fierce Healthcare

Experts weigh in on ways to combat growing antibiotic resistance amid COVID-19. agliadkovskaya. Thu, 11/18/2021 - 15:20.

136
136
article thumbnail

Biohaven wraps patient enrollment for ALS clinical trial arm

Outsourcing Pharma

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

69
article thumbnail

Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research

Pharma Mirror

Rockville, Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients. “This is an exciting opportunity to partner with the leading genetic testing laboratory in India and South Asia to use our collective expertise to help bring faster and more innovative treat

52
article thumbnail

Smartphone-powered trial backs J&J’s Invokana for heart failure

pharmaphorum

Johnson & Johnson’s SGLT2 inhibitor Invokana has been shown to have a significant effect on heart failure symptoms in a clinical trial that relied entirely on remote monitoring of symptoms using a smartphone app. The real-world CHIEF-HF study is said to be the first fully “decentralised, mobile, indication-seeking clinical study” with no need for patients to visit clinic, according to J&J’s pharma division Janssen.

Labelling 105
article thumbnail

Cigna study: How much behavioral health treatment can lower total cost of care

Fierce Healthcare

Cigna study: How much behavioral health treatment can lower total cost of care. pminemyer. Tue, 11/16/2021 - 10:37.

137
137
article thumbnail

IMPACT Celebrates Award from 200th Client

Impact Pharmaceutical Services

Research Triangle Park, NC—November 15, 2021 – In a virtual gathering, Impact Pharmaceutical Services, Inc. (IMPACT) team members opened boxes specially curated to evoke the trust and mutual respect that has grown out of our relationships with now more than 200 clients. In Impact’s 12-year history, we have had the privilege of working with teams […].

52
article thumbnail

ISO 9000 series requirements in Quality Management Systems : A REVIEW

Pharma Tutor

ISO 9000 series requirements in Quality Management Systems : A REVIEW. About Author. Vikas Kumar Prajapati. Organization - Bansal College of Pharmacy, Bhopal(M.P.). Email: vikasprajapati8417@gmail.com. admin. Mon, 11/15/2021 - 16:10. Tags. Articles. Review Articles.

52
article thumbnail

In shock move, Biogen chief medical officer Al Sandrock will stand down

pharmaphorum

Biogen’s chief medical officer Al Sandrock has announced he will retire at the end of the year, ending a 23-year career at the biotech. The architect of many of Biogen’s biggest-selling drugs, Sandrock is bowing out as Biogen is still struggling with the rollout of its controversial new Alzheimer’s disease therapy Aduhelm (aducanumab).

FDA 105
article thumbnail

Rocky road ahead for hospitals in 2022 with rising labor costs, tougher negotiations with payers

Fierce Healthcare

Rocky road ahead for hospitals in 2022 with rising labor costs, tougher negotiations with payers. agliadkovskaya. Mon, 11/15/2021 - 11:24.

Hospitals 126
article thumbnail

Tech Innovations: November 2021

Outsourcing Pharma

This monthâs launches, expanded facilities, partnerships, and other news includes items from Veeva, Hovione, Florence, Medidata, and other notable firms.

52
article thumbnail

Acetaminophen in Osteoarthritis

Med Ed 101

When I was in school, acetaminophen was considered the go agent for the management of osteoarthritis pain. While acetaminophen in osteoarthritis is still possibly a 2nd or 3rd line consideration, more evidence has come to light over the years that maybe it really isn’t that helpful. This review from a few years back demonstrated that […].

40
article thumbnail

Merck wins FDA nod for Keytruda as adjuvant kidney cancer treatment

pharmaphorum

Merck & Co has chalked up another win in drive to move PD-1 inhibitor Keytruda earlier in the treatment pathway for cancer, after the FDA greenlit use of the drug as post-surgery (adjuvant) therapy for renal cell carcinoma (RCC). The checkpoint inhibitor has been approved for use after surgery in patients with RCC – the most common form of kidney cancer – who are at intermediate-high or high risk of the disease recurring.

FDA 105
article thumbnail

Another 12 states take CMS to court over COVID-19 vaccine requirements for healthcare workers

Fierce Healthcare

Another 12 states take CMS to court over COVID-19 vaccine requirements for healthcare workers. dmuoio. Wed, 11/17/2021 - 11:31.

Vaccines 131
article thumbnail

TFF completes dosing in Phase Ib clinical study for asthma drug

Outsourcing Pharma

The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.

52
article thumbnail

A new way to access scientific papers?

Fierce Pharma

A new way to access scientific papers? admin. Mon, 11/15/2021 - 12:01.

56
article thumbnail

Pfizer gets bumper $5.3bn order from US for oral COVID drug

pharmaphorum

Already making big profits from its COVID-19 vaccine, Pfizer looks set to bolt on another big revenue stream with its oral antiviral drug Paxlovid after scoring a $5.3 billion order for the drug from the US government. The deal is dependent on Paxlovid (PF-07321332/ritonavir) being granted either emergency use authorisation (EUA) or full approval, although that looks a safe bet after the drug was shown to reduce COVID-related hospitalisations and deaths by almost 90% in a phase 3 trial.

article thumbnail

Avalere: Providers face 40% hit to Part B reimbursements under Dem drug price reforms

Fierce Healthcare

Avalere: Providers face 40% hit to Part B reimbursements under Dem drug price reforms. rking. Fri, 11/19/2021 - 15:04.

135
135
article thumbnail

Vertex receives CHMP positive opinion for Kaftrio in children with cystic fibrosis

Pharma Times

Those eligible will have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene

53